Singapore markets open in 7 hours 26 minutes

Marpai, Inc. (MRAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4500-0.0300 (-1.21%)
As of 01:21PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.4800
Open2.5400
Bid2.4200 x 100
Ask2.4800 x 100
Day's range2.4006 - 2.5400
52-week range0.3300 - 3.9160
Volume25,486
Avg. volume574,361
Market cap25.236M
Beta (5Y monthly)5.39
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • PR Newswire

    MARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTES

    Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced the sale of new three-year, $11.83 million convertible notes to funds managed by JGB Management Inc.

  • PR Newswire

    MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

    Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent healthcare, today announced financial results for the fourth quarter and fiscal year 2023. The Company expects to hold a webcast to discuss the results on March 27, 2024.

  • PR Newswire

    NASDAQ PANEL GRANTS MARPAI'S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING REQUIREMENTS

    Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced that it received notice from the Nasdaq Hearings Panel ("Panel") of The Nasdaq Stock Market ("Nasdaq") that it has granted the Company an extension to regain compliance with the continued listing requirements for The Nasdaq Capital Mar